Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cortex Pharmaceuticals Inc

+ Add to Watchlist

CORX:US

0.0595 USD 0.0035 6.25%

As of 15:26:52 ET on 03/02/2015.

Snapshot for Cortex Pharmaceuticals Inc (CORX)

Open: 0.0552 Day's Range: 0.0552 - 0.0595 Volume: 15,935
Previous Close: 0.0560 52wk Range: 0.0240 - 0.0900 1-Yr Rtn: +13.81%

Stock Chart for CORX

No chart data available.
  • CORX:US 0.0595
  • 1D
  • 1M
  • 1Y
0.0560
Interactive CORX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CORX

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.0200
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 11.26
Shares Outstanding (M) 201.04
30 Day Average Volume 56,642
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CORX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CORX

Cortex Pharmaceuticals, Inc. discovers, develops, and commercializes pharmaceuticals for the treatment of neurodegenerative diseases and other neurological and psychiatric disorders. The Company develops a family of chemical compounds, known as Ampakines, that enhance the activity of the AMPA-type glutamate receptor.

Mark A VarneyPresident/CEORobert N WeingartenVP/CFO
More Company Profile & Key Executives for CORX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil